Dr. Gutman received his bachelor's in chemistry from Penn State. Following college, he entered the MD/PhD program at Emory and received his PhD in Neuroscience, and MD, in2005. He subsequently completed a Psychiatry residency at Emory University in June 2009. Since then, he has joined CCI as a research scientist. His area of research interest during residency focused on understanding the neurocircuitry of depression, with a focus on advanced neuroimaging techniques including diffusion tensor imaging. While at CCI, he has focused on the analysis and management of digital pathology and radiology images from Glioblastoma Multiforme (GBM). He holds an appointment as Assistant Professor with the Department of Biomedical Informatics at Emory University School of Medicine
Monday, February 6, 2012
Thursday, February 2, 2012
Will Dendritic Cell Subsets Help Us Address the Challenges of Cancer, Autoimmunity & Viral
Dr. Jacques Banchereau is director of the Baylor Institute for Immunology Research in Dallas and holds The Max and Gayle Clampitt Chair for Immunology Research. He received his Ph.D. in biochemistry from the University of Paris in 1980 and later served as director of the Schering Plough Laboratory for Immunological Research near Lyon, France, where he was among the first to discover how to grow human dendritic cells. Dr. Banchereau came to Baylor in 1996 to develop the Institute for Immunology and serves as an adjunct professor at the University of Texas Southwestern Medical School. He also serves on the National Institutes of Health's Experimental Immunology Study Section, Center for Scientific Review, in the area of experimental immunology. He has published more than 275 papers and 170 book chapters and reviews in major international journals, reviews manuscripts for various scientific journals and is a frequent speaker at national and international scientific conferences. His research interests center around various areas of immunology and cancer including dendritic cells, novel cytokines and antibody-producing B lymphocytes.
Friday, January 27, 2012
Wednesday, December 7, 2011
A map of the brain
How can we begin to understand the way the brain works? The same way we begin to understand a city: by making a map. In this visually stunning talk, Allan Jones shows how his team is mapping which genes are turned on in each tiny region, and how it all connects up
Saturday, November 26, 2011
Processing Principles in Surgical Pathology
Ratings & Reviews
2 People Reviewed This Item
Nov. 21, 2011
Dear Readers. I highly recommend this book as a educational tool for pathologist and surgeons in training. I have had the opportunity to read this book and I consider this book meets the most relevant topics and elements in the study of surgical pathology. The illustrations and diagrams have a great quality and help the readers to understand concepts easily and the price of the book is really affordable.
Nov. 21, 2011
I think the authors did an excellent job with this book. Its very easy to understand each chapter, and also has magnificent pathological illustrations.
http://www.lulu.com/product/paperback/processing-principles-in-surgical-pathology/18683571
Saturday, November 12, 2011
The Role of Genetics in Personalised Medicine
Professor Griffiths is a medical researcher who has been studying the genes involved in common human disorders for nearly two decades. Her expertise is in the field of human gene mapping and molecular genetics.
Thursday, August 25, 2011
Monday, August 15, 2011
Targeting the Phosphoinositide-3 Kinase (PI3K) Pathway in Breast Cancer
This podcast reviews current data related to the phosphoinositide-3 kinase (PI3K) pathway, its role in breast cancer, the frequently with which PI3K is aberrant in breast cancer, and the potential clinical implications of using agents that target the PI3K pathway. Jose Baselga is the Chief of the Division of Hematology/Oncology and Associate Director of the Massachusetts General Hospital Cancer Center in Boston where he is also Professor of Medicine at Harvard Medical School. His research interests are in clinical breast cancer and in translational and early clinical research. He conducted the initial clinical trials with the monoclonal antibodies cetuximab and trastuzumab and is leading the clinical development of several new agents including pertuzumab and PI3K inhibitors. His main focus in the laboratory and in the clinic is in the area of novel anti-HER2 agents, in the identification of mechanisms of resistance to anti-HER2 agents and therapeutic approaches to target the PI3K pathway. He is also leading a number of neo-adjuvant trials in breast cancer and has been at the forefront of developing biomarker-based early and translational clinical trials.
Sunday, August 14, 2011
Personalized Medicine and Cancer Research
Dr. Sonali Smith discusses personalized medicine and how it is helping shape current and future cancer research. Sonali Smith, MD is Associate Professor of Medicine at the University of Chicago Medical Center.
Saturday, August 13, 2011
Traditional Therapies to Modern Medicine
Vikas Sukhatme, M.D., Ph.D., presented this lecture as part of the Stephen E. Straus Distinguished Lecture in the Science of Complementary and Alternative Medicine series. Dr. Sukhatme talks about the availability of existing scientifically promising, affordable, and immediately available medical treatments. Traditional medicines have a long history of use and efficacy and offer viable options in addressing other conditions, including cancer. Among these traditions is lifestyle manipulation, specifically dietary adjustments and stress reduction/control, both of which show promise in treating certain forms of cancer. Though more research is needed, Dr. Sukhatme realizes the importance and benefits of studying existing therapies for application to other medical conditions Dr. Sukhatme's research has spanned numerous basic science and clinical arenas, including the discovery of a family of mammalian transcription factors induced by extracellular growth and differentiation cues, and studies on the function of several genes important in kidney cancer and in polycystic kidney disease. His major current interest is in tumor metabolism and tumor immunology and on "outside-the-box" approaches to therapies for advanced cancer. Dr. Sukhatme is the Victor J. Aresty Professor of Medicine, Harvard Medical School, Chief Academic Officer and Harvard Faculty Dean for Academic Programs, Beth Israel Deaconess Medical Center.
Subscribe to:
Posts (Atom)